Momenta Pharmaceuticals Inc (MNTA) - Financial and Strategic SWOT Analysis Review
Momenta Pharmaceuticals Inc (MNTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Momenta Pharmaceuticals Inc (Momenta) is a biotechnology company which specializes in the structural analysis, characterization, and design of complex pharmaceuticals. The company’s marketed products include Glatopa; and Enoxaparin Sodium Injection. Its pipeline portfolio includes biosimilar as well its own novel product candidates. The company utilizes its technology such as Sialylation platform and SIFbody platform for developing generic versions, biosimilars, complex drugs, and potentially interchangeable biologics, and also in the discovery and development of therapeutics for various cancers and autoimmune indications. The company markets its products through its collaborative partners. Momenta is headquartered in Cambridge, Massachusetts, the US.
Momenta Pharmaceuticals Inc Key Recent Developments
May 07,2020: Momenta Pharmaceuticals reports first quarter 2020 financial and operating results
Apr 02,2020: Momenta provides corporate update amid COVID-19 pandemic
Feb 26,2020: Momenta Pharmaceuticals reports fourth quarter and full year 2019 financial results
Jan 13,2020: Momenta provides year-end 2019 update and 2020 outlook
Jan 03,2020: Momenta Pharmaceuticals announces CFO transition
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Momenta Pharmaceuticals Inc (Momenta) is a biotechnology company which specializes in the structural analysis, characterization, and design of complex pharmaceuticals. The company’s marketed products include Glatopa; and Enoxaparin Sodium Injection. Its pipeline portfolio includes biosimilar as well its own novel product candidates. The company utilizes its technology such as Sialylation platform and SIFbody platform for developing generic versions, biosimilars, complex drugs, and potentially interchangeable biologics, and also in the discovery and development of therapeutics for various cancers and autoimmune indications. The company markets its products through its collaborative partners. Momenta is headquartered in Cambridge, Massachusetts, the US.
Momenta Pharmaceuticals Inc Key Recent Developments
May 07,2020: Momenta Pharmaceuticals reports first quarter 2020 financial and operating results
Apr 02,2020: Momenta provides corporate update amid COVID-19 pandemic
Feb 26,2020: Momenta Pharmaceuticals reports fourth quarter and full year 2019 financial results
Jan 13,2020: Momenta provides year-end 2019 update and 2020 outlook
Jan 03,2020: Momenta Pharmaceuticals announces CFO transition
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Momenta Pharmaceuticals Inc - Key Facts
Momenta Pharmaceuticals Inc - Key Employees
Momenta Pharmaceuticals Inc - Key Employee Biographies
Momenta Pharmaceuticals Inc - Major Products and Services
Momenta Pharmaceuticals Inc - History
Momenta Pharmaceuticals Inc - Company Statement
Momenta Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Momenta Pharmaceuticals Inc - Business Description
Product Category: Product Revenue
Performance
Product Category: Research and Development Revenue
Performance
Momenta Pharmaceuticals Inc - Corporate Strategy
Momenta Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Momenta Pharmaceuticals Inc - Strengths
Momenta Pharmaceuticals Inc - Weaknesses
Momenta Pharmaceuticals Inc - Opportunities
Momenta Pharmaceuticals Inc - Threats
Momenta Pharmaceuticals Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Momenta Pharmaceuticals Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
May 07, 2020: Momenta Pharmaceuticals reports first quarter 2020 financial and operating results
Apr 02, 2020: Momenta provides corporate update amid COVID-19 pandemic
Feb 26, 2020: Momenta Pharmaceuticals reports fourth quarter and full year 2019 financial results
Jan 13, 2020: Momenta provides year-end 2019 update and 2020 outlook
Jan 03, 2020: Momenta Pharmaceuticals announces CFO transition
Dec 13, 2019: Momenta Pharmaceuticals appoints Dr. Jane F. Barlow to board of directors
Oct 31, 2019: Momenta Pharmaceuticals reports third quarter 2019 financial and operating results
Sep 19, 2019: Momenta Pharmaceuticals appoints Dr. Donna Grogan to board of directors
Aug 02, 2019: Momenta Pharmaceuticals reports second quarter 2019 financial and operating results
May 02, 2019: Momenta Pharmaceuticals announces first quarter 2019 financial results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Momenta Pharmaceuticals Inc - Key Facts
Momenta Pharmaceuticals Inc - Key Employees
Momenta Pharmaceuticals Inc - Key Employee Biographies
Momenta Pharmaceuticals Inc - Major Products and Services
Momenta Pharmaceuticals Inc - History
Momenta Pharmaceuticals Inc - Company Statement
Momenta Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Momenta Pharmaceuticals Inc - Business Description
Product Category: Product Revenue
Performance
Product Category: Research and Development Revenue
Performance
Momenta Pharmaceuticals Inc - Corporate Strategy
Momenta Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Momenta Pharmaceuticals Inc - Strengths
Momenta Pharmaceuticals Inc - Weaknesses
Momenta Pharmaceuticals Inc - Opportunities
Momenta Pharmaceuticals Inc - Threats
Momenta Pharmaceuticals Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Momenta Pharmaceuticals Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
May 07, 2020: Momenta Pharmaceuticals reports first quarter 2020 financial and operating results
Apr 02, 2020: Momenta provides corporate update amid COVID-19 pandemic
Feb 26, 2020: Momenta Pharmaceuticals reports fourth quarter and full year 2019 financial results
Jan 13, 2020: Momenta provides year-end 2019 update and 2020 outlook
Jan 03, 2020: Momenta Pharmaceuticals announces CFO transition
Dec 13, 2019: Momenta Pharmaceuticals appoints Dr. Jane F. Barlow to board of directors
Oct 31, 2019: Momenta Pharmaceuticals reports third quarter 2019 financial and operating results
Sep 19, 2019: Momenta Pharmaceuticals appoints Dr. Donna Grogan to board of directors
Aug 02, 2019: Momenta Pharmaceuticals reports second quarter 2019 financial and operating results
May 02, 2019: Momenta Pharmaceuticals announces first quarter 2019 financial results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Momenta Pharmaceuticals Inc, Key Facts
Momenta Pharmaceuticals Inc, Key Employees
Momenta Pharmaceuticals Inc, Key Employee Biographies
Momenta Pharmaceuticals Inc, Major Products and Services
Momenta Pharmaceuticals Inc, History
Momenta Pharmaceuticals Inc, Subsidiaries
Momenta Pharmaceuticals Inc, Key Competitors
Momenta Pharmaceuticals Inc, Ratios based on current share price
Momenta Pharmaceuticals Inc, Annual Ratios
Momenta Pharmaceuticals Inc, Annual Ratios (Cont...1)
Momenta Pharmaceuticals Inc, Interim Ratios
Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Momenta Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Momenta Pharmaceuticals Inc, Key Facts
Momenta Pharmaceuticals Inc, Key Employees
Momenta Pharmaceuticals Inc, Key Employee Biographies
Momenta Pharmaceuticals Inc, Major Products and Services
Momenta Pharmaceuticals Inc, History
Momenta Pharmaceuticals Inc, Subsidiaries
Momenta Pharmaceuticals Inc, Key Competitors
Momenta Pharmaceuticals Inc, Ratios based on current share price
Momenta Pharmaceuticals Inc, Annual Ratios
Momenta Pharmaceuticals Inc, Annual Ratios (Cont...1)
Momenta Pharmaceuticals Inc, Interim Ratios
Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Momenta Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Momenta Pharmaceuticals Inc, Performance Chart (2015 - 2019)
Momenta Pharmaceuticals Inc, Ratio Charts
Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
COMPANIES MENTIONED
Coherus BioSciences Inc
Innovent Biologics Inc
Viela Bio Inc
EMD Serono Inc
AB Biosciences Inc
Teva Pharmaceutical Industries Ltd
Biogen Inc
Biocad
Amgen Inc
Sanofi
Synthon Pharmaceuticals Inc
Momenta Pharmaceuticals Inc, Performance Chart (2015 - 2019)
Momenta Pharmaceuticals Inc, Ratio Charts
Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
COMPANIES MENTIONED
Coherus BioSciences Inc
Innovent Biologics Inc
Viela Bio Inc
EMD Serono Inc
AB Biosciences Inc
Teva Pharmaceutical Industries Ltd
Biogen Inc
Biocad
Amgen Inc
Sanofi
Synthon Pharmaceuticals Inc